HealiosHEALIOS K.K.4593東証グロース医薬品FY ending Dec 2023, consolidated, IFRS

What does Healios do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

Figures for this period are incomplete, so the chart cannot be drawn.

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income-¥3.82B

Operating cash flow-¥2.82B

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Operating cash flow-¥2.82B

Net income-¥3.82B

Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Show source documents (1)

EDINET (FSA Japan)
有価証券報告書－第15期(2025/01/01－2025/12/31)
ID S100XTBP2026-03-24Open

Extracted from XBRL: 10 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.